AXN RESEARCH's Role in Targeting Illicit Online Pharmacies

By providing forensic peptide profiling and triage testing tailored for small-volume, internet-sourced samples, AXN RESEARCH strengthens law‑enforcement operations like INTERPOL’s I‑Checkit and Operation Pangea—enabling investigators to rapidly verify the authenticity of peptide-based products sold through illicit online vendors and to produce evidentiary-grade reports for cross-border enforcement actions.

AXN RESEARCH designs high-sensitivity micro-extraction protocols that recover peptides from minimal sample quantities typical of consumer purchases, preserving sequence integrity and diagnostic fragments needed for confident identifications.

Analytical workflows combine targeted LC–MS/MS assays with orthogonal confirmation techniques (e.g., high-resolution accurate-mass measurements and peptide mapping) to distinguish authentic therapeutics from degraded products, analogues, or synthetic mimetics frequently encountered in illicit supplies.

The lab produces forensic-standard method validation packages and chain-of-custody documentation templates so evidence derived from peptide analyses meets admissibility requirements in multiple jurisdictions.

AXN RESEARCH offers rapid triage testing to prioritize samples for full forensic workups, helping enforcement teams allocate limited laboratory resources to cases most likely to yield prosecutable results.

A curated spectral library of legal therapeutic peptides and known illicit analogues supports automated matching and reduces turnaround time for investigators seeking fast verification during active sting operations.

AXN RESEARCH collaborates with INTERPOL and national forensic labs to standardize reporting formats and evidentiary language, ensuring that analytical findings are clear, defensible, and actionable across different legal systems.

Training sessions for law-enforcement partners cover sample collection from online orders, preservation during transit, and preliminary field screening, reducing contamination risk and improving downstream analytical success.

AXN RESEARCH participates in proficiency testing and inter-laboratory comparisons focused on forensic peptide detection to demonstrate competence and harmonize performance benchmarks used in cross-border cases.

When products lack reference spectra, AXN RESEARCH’s non-targeted discovery workflows and de novo sequencing capabilities can identify novel analogues or modifications, supplying investigators with molecular leads for attribution and source-tracing.

The organization integrates secure evidence-management systems and encrypted result delivery to protect chain-of-custody integrity and maintain confidentiality during active investigations and prosecutions.

AXN RESEARCH assists in correlating analytical signatures with packaging, labeling, and shipment metadata to support broader investigative leads—linking product chemotypes to manufacturers, distributors, or repeat offenders.

By producing concise, court-ready technical summaries and expert witness statements, AXN RESEARCH helps translate complex peptide-chemistry findings into legally meaningful evidence for prosecutors and judges.

AXN RESEARCH contributes to operational intelligence by aggregating anonymized analytics from multiple seizures, enabling INTERPOL and partners to identify patterns in illicit peptide formulations, recurring analogues, or supply-chain hotspots.

Rapid-response analytical capacity enables AXN RESEARCH to support time-sensitive enforcement windows—such as coordinating analyses during synchronized global actions like Operation Pangea—so evidence is available for simultaneous cross-border interventions.

AXN RESEARCH advises on emerging threats from novel peptide mimetics marketed online and helps law-enforcement adapt screening panels to include high-risk analogues identified through market monitoring.

Collaborative exercises and tabletop simulations with INTERPOL refine protocols for sample handover, result dissemination, and joint press communications while maintaining evidentiary and chain-of-custody standards.

AXN RESEARCH’s documentation of validated limits of detection and specificity for forensic assays provides courts with transparent performance metrics, reducing challenges to analytical credibility during prosecutions.

The group fosters partnerships with customs agencies and postal inspectors, supplying guidance on prioritizing shipments for testing and on preserving small, perishable peptide samples during seizure and transport.

Long-term capacity-building includes transferring turnkey forensic peptide workflows to regional forensic centers, decreasing dependence on centralized labs and accelerating local response to illicit online pharmacy threats.

By combining micro-sampling methods, validated forensic assays, secure evidence handling, and collaborative intelligence-sharing, AXN RESEARCH amplifies INTERPOL’s ability to disrupt illicit online pharmacies trafficking peptide-based products and to support successful cross-border enforcement actions.